Royal London Asset Management LTD Legend Biotech Corp Transaction History
Royal London Asset Management LTD
- $44.9 Billion
- Q3 2025
A detailed history of Royal London Asset Management LTD transactions in Legend Biotech Corp stock. As of the latest transaction made, Royal London Asset Management LTD holds 61,600 shares of LEGN stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,600
Previous 60,800
1.32%
Holding current value
$1.87 Million
Previous $2.16 Million
6.91%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding LEGN
# of Institutions
224Shares Held
57.2MCall Options Held
231KPut Options Held
626K-
Westfield Capital Management CO LP Boston, MA6.09MShares$185 Million0.91% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$181 Million5.86% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$173 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.82MShares$116 Million3.74% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$89.7 Million1.8% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.07B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...